- Corporate Officers - D
- Deerfield Private Design Fund Iv, L.p.
Insider Trading History of Deerfield Private Design Fund Iv, L.p.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Deerfield Private Design Fund Iv, L.p. since 2018.
This trader's CIK number is 1680307.
At the time of last reporting, Deerfield Private Design Fund Iv, L.p. was the Officer of Ars Pharmaceuticals, Inc.. (stock ticker symbol SPRY).
Also see all insider trading activities at Ars Pharmaceuticals, Inc..
Note that in the past
Deerfield Private Design Fund IV, L.P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Edgewise Therapeutics, Inc. (EWTX) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | EWTX | 625,000 | $10,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Larimar Therapeutics, Inc. (LRMR) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | LRMR | 11,111,108 | $34,999,990 | 0 | $0 | 0 | $0 |
| 2021 | LRMR | 685,710 | $5,999,962 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Singular Genomics Systems, Inc. (OMIC) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | OMIC | 1,500,000 | $33,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arvinas, Inc. (ARVN) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ARVN | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ars Pharmaceuticals, Inc. (SPRY) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | SPRY | 0 | $0 | 740,149 | $13,663,150 | 0 | $0 |
| 2024 | SPRY | 0 | $0 | 563,270 | $10,014,542 | 0 | $0 |
Yearly summary of insider trading at Adapthealth Corp. (DFBH) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | DFBH | 2,500,000 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nuvalent, Inc. (NUVL) by Deerfield Private Design Fund Iv, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | NUVL | 0 | $0 | 2,000,000 | $195,500,000 | 0 | $0 |
| 2022 | NUVL | 650,000 | $21,775,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Deerfield Private Design Fund Iv, L.p.:
1. Edgewise Therapeutics, Inc. (EWTX)
2. Larimar Therapeutics, Inc. (LRMR)
3. Singular Genomics Systems, Inc. (OMIC)
4. Arvinas, Inc. (ARVN)
5. Ars Pharmaceuticals, Inc. (SPRY)
6. Adapthealth Corp. (DFBH)
7. Nuvalent, Inc. (NUVL)
Table 1. Insider trading of Edgewise Therapeutics, Inc. (EWTX) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-30 | EWTX | Buy | 625,000 | 16.00 | 10,000,000 |
Table 2. Insider trading of Larimar Therapeutics, Inc. (LRMR) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-16 | LRMR | Buy | 11,111,108 | 3.15 | 34,999,990 |
| 2021-06-30 | LRMR | Buy | 685,710 | 8.75 | 5,999,962 |
Table 3. Insider trading of Singular Genomics Systems, Inc. (OMIC) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-01 | OMIC | Buy | 1,500,000 | 22.00 | 33,000,000 |
Table 4. Insider trading of Arvinas, Inc. (ARVN) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-10-01 | ARVN | Buy | 312,500 | 16.00 | 5,000,000 |
Table 5. Insider trading of Ars Pharmaceuticals, Inc. (SPRY) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-27 | SPRY | Sale | 740,149 | 18.46 | 13,663,150 |
| 2024-11-11 | SPRY | Sale | 528,456 | 17.80 | 9,406,516 |
| 2024-11-12 | SPRY | Sale | 34,814 | 17.46 | 608,026 |
Table 6. Insider trading of Adapthealth Corp. (DFBH) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-02-21 | DFBH | Buy | 2,500,000 | .00 | 0 |
Table 7. Insider trading of Nuvalent, Inc. (NUVL) by Deerfield Private Design Fund Iv, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-10-22 | NUVL | Sale | 2,000,000 | 97.75 | 195,500,000 |
| 2022-11-03 | NUVL | Buy | 650,000 | 33.50 | 21,775,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Deerfield Private Design Fund Iv, L.p.
(Officer of Ars Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.